Aridis Pharmaceuticals shares surge in US market debut

Source: Dukascopy Bank SA
Aridis Pharmaceuticals, the biotechnology company, have surged as much as 5.4% to $13.70 in the firm's US market debut this Tuesday, bringing its market value to $102.7M at the opening price.
Back to articles

Actual Topics

Wed, 15 Aug 2018 07:01:21 GMT

Diamondback to acquire Energen for $9.2B

Diamondback Energy, the US gas and oil producer, agreed on Tuesday to acquire its rival Energen in the all-stock deal worth $9.2B to boost the company's presence in the country.

Wed, 15 Aug 2018 06:36:59 GMT

US chipmaker Intel unveils more chip flaws

The US chipmaker Intel announced on Tuesday there were three more flaws in its microprocessors that raises a risk of accessing the computer memory's certain data by the third parties.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.